LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS

Liposomal compositions comprising peptide epoxyketone compounds are described, as well as methods of making and using such liposomal compositions. These liposomal compositions enhance the therapeutic window of peptide epoxyketone compounds by improving in vivo half-life relative to non-liposomal com...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KIRK, CHRISTOPHER, JUSTIN, WANG, ZHENGPING, CHU, KATHERINE, A, CHAN, ELENA, T, FANG, YING, JIANG, JING, JONES, JEFFREY, JOSEPH, MUCHAMUEL, TONY, MARCEL, JUMAA, MOUHANNAD
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator KIRK, CHRISTOPHER, JUSTIN
WANG, ZHENGPING
CHU, KATHERINE, A
CHAN, ELENA, T
FANG, YING
JIANG, JING
JONES, JEFFREY, JOSEPH
MUCHAMUEL, TONY, MARCEL
JUMAA, MOUHANNAD
description Liposomal compositions comprising peptide epoxyketone compounds are described, as well as methods of making and using such liposomal compositions. These liposomal compositions enhance the therapeutic window of peptide epoxyketone compounds by improving in vivo half-life relative to non-liposomal compositions comprising peptide epoxyketone compounds, providing desirable pharmacodynamic profiles, and providing anti-tumor activity in a human tumor xenograft model, greater than or equal to non-liposomal compositions comprising peptide epoxyketone compounds. Further, experiments performed in support of the present invention demonstrated improved tolerability of liposomal compositions comprising peptide epoxyketone compounds.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2874605A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2874605A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2874605A13</originalsourceid><addsrcrecordid>eNrjZHD08QzwD_b3dfRRcPb3BTI9Qzz9_YIV_N0UXAP8IyK9XUP8_Vx1nRyDXV0UAoL8Q1wdgapdFTz9PDydPEP8g4J5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CRhbmJmYGpo6ExEUoA1YgrPQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS</title><source>esp@cenet</source><creator>KIRK, CHRISTOPHER, JUSTIN ; WANG, ZHENGPING ; CHU, KATHERINE, A ; CHAN, ELENA, T ; FANG, YING ; JIANG, JING ; JONES, JEFFREY, JOSEPH ; MUCHAMUEL, TONY, MARCEL ; JUMAA, MOUHANNAD</creator><creatorcontrib>KIRK, CHRISTOPHER, JUSTIN ; WANG, ZHENGPING ; CHU, KATHERINE, A ; CHAN, ELENA, T ; FANG, YING ; JIANG, JING ; JONES, JEFFREY, JOSEPH ; MUCHAMUEL, TONY, MARCEL ; JUMAA, MOUHANNAD</creatorcontrib><description>Liposomal compositions comprising peptide epoxyketone compounds are described, as well as methods of making and using such liposomal compositions. These liposomal compositions enhance the therapeutic window of peptide epoxyketone compounds by improving in vivo half-life relative to non-liposomal compositions comprising peptide epoxyketone compounds, providing desirable pharmacodynamic profiles, and providing anti-tumor activity in a human tumor xenograft model, greater than or equal to non-liposomal compositions comprising peptide epoxyketone compounds. Further, experiments performed in support of the present invention demonstrated improved tolerability of liposomal compositions comprising peptide epoxyketone compounds.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150527&amp;DB=EPODOC&amp;CC=EP&amp;NR=2874605A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20150527&amp;DB=EPODOC&amp;CC=EP&amp;NR=2874605A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KIRK, CHRISTOPHER, JUSTIN</creatorcontrib><creatorcontrib>WANG, ZHENGPING</creatorcontrib><creatorcontrib>CHU, KATHERINE, A</creatorcontrib><creatorcontrib>CHAN, ELENA, T</creatorcontrib><creatorcontrib>FANG, YING</creatorcontrib><creatorcontrib>JIANG, JING</creatorcontrib><creatorcontrib>JONES, JEFFREY, JOSEPH</creatorcontrib><creatorcontrib>MUCHAMUEL, TONY, MARCEL</creatorcontrib><creatorcontrib>JUMAA, MOUHANNAD</creatorcontrib><title>LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS</title><description>Liposomal compositions comprising peptide epoxyketone compounds are described, as well as methods of making and using such liposomal compositions. These liposomal compositions enhance the therapeutic window of peptide epoxyketone compounds by improving in vivo half-life relative to non-liposomal compositions comprising peptide epoxyketone compounds, providing desirable pharmacodynamic profiles, and providing anti-tumor activity in a human tumor xenograft model, greater than or equal to non-liposomal compositions comprising peptide epoxyketone compounds. Further, experiments performed in support of the present invention demonstrated improved tolerability of liposomal compositions comprising peptide epoxyketone compounds.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHD08QzwD_b3dfRRcPb3BTI9Qzz9_YIV_N0UXAP8IyK9XUP8_Vx1nRyDXV0UAoL8Q1wdgapdFTz9PDydPEP8g4J5GFjTEnOKU3mhNDeDgptriLOHbmpBfnxqcUFicmpeakm8a4CRhbmJmYGpo6ExEUoA1YgrPQ</recordid><startdate>20150527</startdate><enddate>20150527</enddate><creator>KIRK, CHRISTOPHER, JUSTIN</creator><creator>WANG, ZHENGPING</creator><creator>CHU, KATHERINE, A</creator><creator>CHAN, ELENA, T</creator><creator>FANG, YING</creator><creator>JIANG, JING</creator><creator>JONES, JEFFREY, JOSEPH</creator><creator>MUCHAMUEL, TONY, MARCEL</creator><creator>JUMAA, MOUHANNAD</creator><scope>EVB</scope></search><sort><creationdate>20150527</creationdate><title>LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS</title><author>KIRK, CHRISTOPHER, JUSTIN ; WANG, ZHENGPING ; CHU, KATHERINE, A ; CHAN, ELENA, T ; FANG, YING ; JIANG, JING ; JONES, JEFFREY, JOSEPH ; MUCHAMUEL, TONY, MARCEL ; JUMAA, MOUHANNAD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2874605A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KIRK, CHRISTOPHER, JUSTIN</creatorcontrib><creatorcontrib>WANG, ZHENGPING</creatorcontrib><creatorcontrib>CHU, KATHERINE, A</creatorcontrib><creatorcontrib>CHAN, ELENA, T</creatorcontrib><creatorcontrib>FANG, YING</creatorcontrib><creatorcontrib>JIANG, JING</creatorcontrib><creatorcontrib>JONES, JEFFREY, JOSEPH</creatorcontrib><creatorcontrib>MUCHAMUEL, TONY, MARCEL</creatorcontrib><creatorcontrib>JUMAA, MOUHANNAD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KIRK, CHRISTOPHER, JUSTIN</au><au>WANG, ZHENGPING</au><au>CHU, KATHERINE, A</au><au>CHAN, ELENA, T</au><au>FANG, YING</au><au>JIANG, JING</au><au>JONES, JEFFREY, JOSEPH</au><au>MUCHAMUEL, TONY, MARCEL</au><au>JUMAA, MOUHANNAD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS</title><date>2015-05-27</date><risdate>2015</risdate><abstract>Liposomal compositions comprising peptide epoxyketone compounds are described, as well as methods of making and using such liposomal compositions. These liposomal compositions enhance the therapeutic window of peptide epoxyketone compounds by improving in vivo half-life relative to non-liposomal compositions comprising peptide epoxyketone compounds, providing desirable pharmacodynamic profiles, and providing anti-tumor activity in a human tumor xenograft model, greater than or equal to non-liposomal compositions comprising peptide epoxyketone compounds. Further, experiments performed in support of the present invention demonstrated improved tolerability of liposomal compositions comprising peptide epoxyketone compounds.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP2874605A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T18%3A38%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KIRK,%20CHRISTOPHER,%20JUSTIN&rft.date=2015-05-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2874605A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true